Presentation is loading. Please wait.

Presentation is loading. Please wait.

Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,

Similar presentations


Presentation on theme: "Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,"— Presentation transcript:

1 Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial 
Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens, Nikolaos P. Polyzos, Dominic Stoop, Michel Camus, Paul Devroey  Reproductive BioMedicine Online  Volume 24, Issue 3, Pages (March 2012) DOI: /j.rbmo Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions

2 Figure 1 Schematic overview of both treatment groups. GnRH=gonadotrophin-releasing hormone; HCG=human chorionic gonadotrophin. Reproductive BioMedicine Online  , DOI: ( /j.rbmo ) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions

3 Figure 2 Study flow chart diagram. OR=oocyte retrival.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo ) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions

4 Figure 3 Oocyte retrieval by day in both treatment groups. The distribution of oocyte retrieval by day for patients randomized to control or pretreatment group was analysed by the Fisher’s exact test (P=0.039). Reproductive BioMedicine Online  , DOI: ( /j.rbmo ) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions


Download ppt "Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,"

Similar presentations


Ads by Google